Key result
Cytological evaluation of 120 pericardial effusion cases identified 80% as benign and 20% as malignant.
Why the study?
Cytological examination of pericardial effusion fluids is important for diagnosing underlying disease etiology, cancer staging, and prognosis.
What is the frequency of benign versus malignant etiologies in cytological evaluation of pericardial effusions?
Observational (n=120)
No
What is the frequency of benign versus malignant etiologies in cytological evaluation of pericardial effusions?
Cytological evaluation of pericardial fluid is a convenient and cost-effective method for diagnosing underlying etiologies, with 20% of cases in this cohort identified as malignant.
Informs differential diagnosis of pericardial effusion; extends observational data but requires prospective validation.
BACKGROUND: Cytological examination of pericardial effusion fluids is important in diagnosing the etiology of underlying disease, staging, and prognosis of cancer. AIMS AND OBJECTIVES: (1) To study cytological evaluation of pericardial effusions in various pathological conditions in a tertiary care center. (2) To analyze their frequency and clincopathological correlation of the diagnosis. MATERIALS AND METHODS: December 2016. The study sample included all the pericardial effusions submitted in the pathology department for cytological evaluation. Clinical details and relevant parameters correlated with clinical findings. Each fluid underwent cytospin and cytocentrifuge along with preparation of conventional smears. RESULTS: Of 120 cases, 80% were of benign effusion and 20% were of malignant effusion. Male-to-female ratio was 1.44:1 with patient age ranging from 3 to 90 years. CONCLUSION: Benign effusions can been seen in younger age group and malignant ones in the older age group. The preliminary pericardial fluid analysis in resource-limited settings is the most convenient and cost-effective method for accurate diagnosis. It reduces the demand of invasive investigations and its complications. At times, it is the first test to point toward underlying malignant process thereby affecting the prognosis, survival, and treatment outcome of the patient.
No takes yet. Share an insight, caveat, or question.
Yadav et al. (2019) conducted an observational in Pericardial effusion (n=120). Cytological evaluation was evaluated on Frequency of benign vs malignant effusion. Cytological evaluation of 120 pericardial effusion cases identified 80% as benign and 20% as malignant.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: